John L. Brottem - 30 Nov 2022 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role: General Counsel
Signature: John L Brottem
Issuer symbol: OM
Transactions as of: 30 Nov 2022
Net transactions value: -$138,523
Form type: 4
Filing time: 01 Dec 2022, 19:00:45 UTC
Previous filing: 21 Nov 2022
Next filing: 09 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OM	Common Stock	Options Exercise	$120,974	+12,761	+41%	$9.48	43,805	30 Nov 2022	Direct
transaction	OM	Common Stock	Sale	$259,497	-12,761	-29%	$20.34	31,044	30 Nov 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OM	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-12,761	-33%	$0.000000	25,462	30 Nov 2022	Common Stock	12,761	$9.48	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $20.29 to $20.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote.
F2	This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.

Content

The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $20.29 to $20.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote.

This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.